Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Express Scripts
Johnson and Johnson
Boehringer Ingelheim

Last Updated: January 24, 2020

DrugPatentWatch Database Preview

Drugs in Development Information for Vintafolide

Join the DrugPatentWatch Referral Program
Get access to a free drug patent landscape report or a free one-month subscription

« Back to Dashboard

What is the drug development status for Vintafolide?

Vintafolide is an investigational drug.

There have been 9 clinical trials for Vintafolide. The most recent clinical trial was a Phase 2 trial, which was initiated on August 1st 2007.

The most common disease conditions in clinical trials are Lung Neoplasms, Ovarian Neoplasms, and Adenocarcinoma. The leading clinical trial sponsors are Endocyte and [disabled in preview].

Recent Clinical Trials for Vintafolide
Safety and Efficacy Study of Vintafolide and Vintafolide Plus Paclitaxel Compared to Paclitaxel Alone in Participants With Triple Negative Breast Cancer (TNBC) (MK-8109-004)EndocytePhase 2
A Study of Vintafolide (MK-8109) in Participants With Advanced Solid Tumor (MK-8109-011)EndocytePhase 1
A Study of MK-8109 (Vintafolide) Given Alone or With Chemotherapy in Participants With Advanced Cancers (MK-8109-001)EndocytePhase 1

See all Vintafolide clinical trials

Clinical Trial Summary for Vintafolide

Top disease conditions for Vintafolide
Top clinical trial sponsors for Vintafolide

See all Vintafolide clinical trials

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.